Gene · 9133
Papers2,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,908
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers. | Biol Proced Online | 2023 | 37268895 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals the potential biological mechanism of AIS and lung adenocarcinoma. | Front Neurol | 2023 | 37265472 | PubTator, text mining | PubMed |
| Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics. | Pharmaceuticals (Basel) | 2023 | 37259344 | PubTator, text mining | PubMed |
| NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma. | Hereditas | 2023 | 37254219 | PubTator, text mining | PubMed |
| Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases. | Front Cardiovasc Med | 2023 | 37252119 | PubTator, text mining | PubMed |
| A specific dispiropiperazine derivative that arrests cell cycle, induces apoptosis, necrosis and DNA damage. | Sci Rep | 2023 | 37248333 | PubTator, text mining | PubMed |
| FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases. | Biomolecules | 2023 | 37238726 | PubTator, text mining | PubMed |
| Epigenetic and Tumor Microenvironment for Prognosis of Patients with Gastric Cancer. | Biomolecules | 2023 | 37238607 | PubTator, text mining | PubMed |
| In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma. | Medicine (Baltimore) | 2023 | 37233443 | PubTator, text mining | PubMed |
| Prolactin Regulates Testicular Gene Expression and Cell Cycle Processes Predominantly via JAK2/STAT5 Pathway in the Male Rat. | Endocrinology | 2023 | 37232379 | PubTator, text mining | PubMed |
| Decoding protein methylation function with thermal stability analysis. | Nat Commun | 2023 | 37230995 | PubTator, text mining | PubMed |
| PER2 integrates circadian disruption and pituitary tumorigenesis. | Theranostics | 2023 | 37215573 | PubTator, text mining | PubMed |
| SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril. | Antiviral Res | 2023 | 37207821 | PubTator, text mining | PubMed |
| The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma. | Front Immunol | 2023 | 37207200 | PubTator, text mining | PubMed |
| Profile analysis of differentially expressed long non‑coding RNAs in metabolic memory induced by high glucose in human umbilical vein endothelial cells. | Exp Ther Med | 2023 | 37206566 | PubTator, text mining | PubMed |
| The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response. | Front Oncol | 2023 | 37197417 | PubTator, text mining | PubMed |
| MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes. | Cancers (Basel) | 2023 | 37190222 | PubTator, text mining | PubMed |
| The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway. | Front Oncol | 2023 | 37182151 | PubTator, text mining | PubMed |
| TP53 Signature Can Predict Pathological Response From Neoadjuvant Chemotherapy and Is a Prognostic Factor in Patients With Residual Disease. | Breast Cancer (Auckl) | 2023 | 37181950 | PubTator, text mining | PubMed |
| Increased FOXM1 Expression was Associated with the Prognosis and the Recruitment of Neutrophils in Endometrial Cancer. | J Immunol Res | 2023 | 37159818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9133/papers?page=15